• Assay Selection Tool

BellBrook Labs

  • Products
    • Transcreener® HTS Assays
      • Transcreener® ADP² Kinase Assay
      • Transcreener® ADO CD73 Assay
      • Transcreener® AMP²/GMP² Phosphodiesterase Assay
      • Transcreener® cGAMP cGAS Assay
      • Transcreener® EPIGEN SAH Methyltransferase Assay
      • Transcreener® GDP GTPase Assay Kits
      • Transcreener® UDP² Glycosyltransferase Assay
      • Transcreener® 2-5A OAS Assay
    • AptaFluor® HTS Assays
      • AptaFluor® SAH Methyltransferase Assay
    • HTS Assays by Target Family
      • Kinase Assay Kits
      • ATPase Assay Kits
      • Glycosyltransferase Assay Kits
      • GTPase Assay Kits
        • GAP Assay Kits
        • GEF Assay Kits
      • Ligase and Synthetase Assay Kits
      • Methyltransferase Assay Kits
      • Phosphodiesterase Assay Kits
    • HTS Assays by Target
      • Adenosine Kinase Assay Kits
      • AMPK Assay Kits
      • CD39 Assay Kits
      • CD73 Assay Kits
      • cGAS Assay Kits
      • DDX3 Assay Kits
      • ENPP1 Assay Kits
      • EZH2 Assay Kits
      • IKK-beta Assay Kits
      • IRAK4 Assay Kits
      • JAK1 Assay Kits
      • JAK3 Assay Kits
      • NSP13 Assay Kits
      • NUDT5 Assay Kits
      • OAS Assay Kits
      • PKR Assay Kits
      • TBK1 Assay Kits
    • Recombinant Enzymes
      • Human cGAS Enzyme
      • Mouse cGAS Enzyme
      • Human DDX3 Enzyme
      • Human OAS1 Enzyme
    • Assay Plates
    • Ordering Information
  • Services
    • Assay Development Services
    • Lead Discovery Services
    • CD38 Assay Services
    • GTPase Profiling Services
  • Innate Immunity
    • ADK Activity Assays
    • AMPK Activity Assays
    • cGAS Activity Assays
    • CD73 Activity Assays
    • CD38 Activity Assay Services
    • CD39 Activity Assays
    • DDX3 Activity Assays
    • ENPP1 Activity Assays
    • IKK-beta Activity Assays
    • IRAK4 Activity Assays
    • JAK1 Activity Assays
    • JAK3 Activity Assays
    • NSP13 Activity Assays
    • OAS1 Activity Assays
    • PKR Activity Assays
    • TBK1 Activity Assays
  • Resources
    • Technical Manuals
    • Transcreener® Assays – Instrument Compatibility
    • Application Notes
    • Posters and Presentations
    • Publications
    • Transcreener® FAQ’s
    • Guides
      • Residence Time Guide
      • Hit Prioritization Guide
      • Kinases in Innate Immunity
  • Company
    • President’s Message
    • International Distributors
    • Careers
    • Downloads
    • Contact Us
  • Blog
  • MY CART
    No products in cart.

New TR-FRET Readout Now Available with the Transcreener cGAMP cGAS Assay

by Bellbrook Labs / Thursday, 10 December 2020 / Published in News, Products
New cGAS TR-FRET Assay

Launched in November 2019, the Transcreener cGAMP cGAS Assay has generated a great deal of interest in the drug discovery community. While fluorescence polarization (FP) readouts offer a stable and robust option, some researchers prefer time-resolved Förster-resonance-energy-transfer (TR-FRET) readouts for large screens. After months of development, BellBrook Labs is pleased to announce the addition of a TR-FRET readout to the Transcreener cGAMP cGAS Assay family.

Cyclic GMP-AMP synthase, or cGAS, is an enzyme recently identified as an innate immunity target. The cGAS-STING pathway has been shown to play a role in innate immune response, inflammation, tissue repair, infectious disease, and viral persistence. Investigating cGAS signaling events may lead to the discovery of small molecule modulators of this pathway for therapeutic intervention. High Throughput Screening is a powerful tool for cGAS discovery. In combination with Transcreener cGAMP cGAS Assay, researchers can use HTS to screen thousands of chemical compounds and discover active molecules, targeting the cause of inflammatory diseases. Upon detection of a positive hit in the HTS assay, the candidate compound can be advanced into functional and biochemical studies further to explore its potential as a novel therapeutic lead molecule.

BellBrooks customers provide a driving force to produce assays that enable quality data to accelerate their discovery efforts. Developing multiple fluorescent readouts allows researchers more tools for discovery. TR-FRET is one preferred option by many in drug discovery, especially in high throughput screening where time-gated measurements can help eliminate interference from the fluorescence of test compounds. The Transcreener cGAMP cGAS TR-FRET Assay is a simple mix-and-read format that provides excellent Z’ of greater than 0.7 at cGAMP ranges between 0.5 µM and 100 µM. It employs a far-red ATTO 647 tracer that further minimizes interference from fluorescent compounds and light scattering.

BellBrook Labs is a world leader in small molecule HTS research tools – our technology enables researchers to measure enzyme activity in a simple, high-throughput manner. Before the development of this assay, there were few options available for monitoring cGAS activity. Now, with Transcreener’s combination of two highly-sensitive fluorescent assays with robust high throughput capabilities, researchers can more easily screen for small molecule modulators of cGAS.

About BellBrook Labs:

BellBrook Labs is dedicated to accelerating drug discovery and biological research by providing innovative high throughput screening solutions. BellBrook’s core technology Transcreener is a universal, homogenous biochemical assay platform based on the detection of nucleotides that makes it easy to screen thousands of different enzymes. These include validated targets like kinases and emerging targets like ATPases, GTPases, methyltransferases, and glycosyltransferases. Detection reagents and services from BellBrook Labs help researchers progress toward more effective therapies for cancer and other debilitating diseases.

Tagged under: cgas assay, cGAS Inhibitors, Transcreener cGAMP cGAS Assay

What you can read next

New Transcreener cGAS Assay
BellBrook Labs Launches Transcreener cGAS Activity Assay to Accelerate Drug Discovery
Transcreener ADP Assay Aids in Discovery of RIPK2 Inhibitors for Autoinflammation
Inhibitors of ENPP1 SLAS Discovery
New Publication by the Scientists at BellBrook Labs – Development of a High-Throughput Assay to Identify Inhibitors of ENPP1

Categories

  • Company
  • Emerging Targets
  • Epigenetics
  • HTS Assays
  • Innate Immunity
  • Neurodegenerative Diseases
  • News
  • Products
  • Resources
  • Success Stories
  • Uncategorized

Recent Posts

  • Info book on cancer and RAFK1's relation

    RAF1 & Immunity: A Future Model For Cancer Research?

    RAF1, also known as c-Raf, is a member of the R...
  • OAS1 The Cost of Host Defense

    OAS1: The Cost of Host Defense

    OAS1 (Oligoadenylate synthetase 1) is induced b...
  • Scientist Studying DDX41

    DDX41 as a Sensor, Suppressor, and Modulator

    DDX41 [DEAD (Asp-Glu-Ala-Asp) Box Polypeptide 4...
  • Scientist Studying ALKPK1

    The Role of ALPK1 in Health and Disease

    ALPK1 (Alpha Kinase 1) is an atypical serine/th...
  • DHX36 RNA Helicase Unwinds G4 RNA Structures

    Resolving the Many Roles of DHX36

    While most researchers are familiar with canoni...

Archives

BellBrook Labs
5500 Nobel Drive, Suite 230
Madison, Wisconsin 53711 USA
(608) 443-2400

info@bellbrooklabs.com

 Copyright © 2022 BellBrook Labs | All Rights Reserved | Privacy Policy | Terms of Use | FCOI | Sitemap

TOP